Electrophysiologic Properties of Ethacrynic Acid in Man

Gould, Lawrence; Gopalaswamy, C.; Chandy, F.; Abdou, O.
November 1983
Angiology;Nov1983, Vol. 34 Issue 11, p747
Academic Journal
Ethacrynic acid is a potent oral diuretic and saluretic agent. It has been used extensively in the treatment of heart failure and its effects on cardiovascular dynamics are well established. The clinical relief of the symptoms of pulmonary congestion frequently precedes any demonstrable diuretic effect suggesting that extra renal factors may also be involved. In spite of ethacrynic acid's wide use in the treatment of heart failure and hypertension, there is no information on the electrophysiologic properties of the drug in man. The present study involving 10 human subjects was undertaken to determine what effect intravenously administered ethacrynic acid has on the human conduction system.


Related Articles

  • Information from Your Family Doctor. What Should I Know About Heart Failure?  // American Family Physician;10/15/2001, Vol. 64 Issue 8, p1399 

    Presents information on heart failure. How one might feel with heart failure; Treatment options; Question of whether it can be cured; Ways to feel better.

  • Questions & Answers.  // Drug Safety;2004 Supplement 1, Vol. 27, p25 

    The article discusses the answers on drug safety-related queries. It describes the two main mechanisms that have been proposed for the occurrence of drug-induced agranulocytosis, namely, immune-mediated and toxic injury; It details the racial differences in therapeutic responses to heart failure...

  • Study of adherence to exercise in heart failure: the HEART camp trial protocol. Pozeh, Bunny J.; Duncan, Kathleen; Hertzog, Melody; McGuire, Rita; Norman, Joseph F.; Artinian, Nancy T.; Keteyian, Steven J. // BMC Cardiovascular Disorders;2014, Vol. 14 Issue 1, p1 

    Background Adherence to the Heart Failure Society of America (HFSA) 2010 guidelines recommending 30 minutes of supervised moderate intensity exercise five days per week is difficult for patients with heart failure (HF). Innovative programs are needed to assist HF patients to adhere to long-term...

  • Trial of a family-based education program for heart failure patients in rural Thailand. Srisuk, Nittaya; Cameron, Jan; Ski, Chantal F.; Thompson, David R. // BMC Cardiovascular Disorders;2014, Vol. 14 Issue 1, p1 

    Background Heart failure (HF) significantly impacts on the daily lives of patients and their carers. In Western society HF education programs have increased patient and carer knowledge and improved health-related quality of life. However, there is a paucity of such evidence in Asia. For example,...

  • Levosimendan: a decade of experience in Europe built on years of evidence. Parissis, John; Toller, Wolfgang; Franco, Fatima; Delgado, Juan F.; Danou, Fotini; Llorens-Soriano, Pere; Karpati, Peter C.J.; Nieminen, Markku S.; Mebazaa, Alexandre; Follath, Ferenc // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 2, p234 

    Abstract: Recent European Society of Cardiology''s (ESC) guidelines on the diagnosis and treatment of acute heart failure (AHF), suggest that an essential target in the management of these patients is to improve symptoms within hours, which should persist until hospital release, also protecting...

  • COMPLIANCE OF THE PERIPHERAL CAPACITANCE VESSELS IN PATIENTS WITH CONGESTIVE HEART FAILURE. Kato, Masataka; Suzuki, Tomoyuki; Ogino, Tadayoshi; Kimura, Takeshi // Angiology;Dec1976, Vol. 27 Issue 12, p698 

    A method for measuring compliance of the peripheral capacitance vessels is reported, and the values of compliance in patients with congestive heart failure are compared with those in normal subjects. Peripheral venous compliance and right brachial venous pressure in both patients with congestive...

  • Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project. Lip, G. Y. H.; Khan, H.; Bhatnagar, A.; Brahmabhatt, N.; Crook, P.; Davies, M. K. // Heart;Sep2004, Vol. 90 Issue 9, p1016 

    Objective: To investigate further the hypothesis that ethnic groups would have different levels of knowledge and perceptions of congestive heart failure (CHF) and treatments for this condition, a cross sectional survey was conducted of patients who were attending the heart failure clinics in two...

  • No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial.  // MD Conference Express;May2011, p20 

    The article focuses on the Surgical Treatment of Ischemic Heart Failure (STICH) trial. The trial reveals that no mortality benefit from coronary artery bypass grafting (CABG) in addition to intensive guideline-based medical therapy compared with medical therapy alone. The STICH trial was...

  • Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment. McMurray, John J. V. // Kidney International;Oct2005, Vol. 68 Issue 4, p1419 

    Presents a study on the possibility of patients with chronic kidney disease to have a heightened risk of cardiovascular disease. Use of effective therapeutic interventions; Effectiveness of strategy for reducing population burden; Inclusion of heart failure and coronary heart disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics